Core Viewpoint - The Hong Kong Securities and Futures Commission conducted an inquiry into the shareholding distribution of Ximing Life Science Technology Group Limited, revealing a highly concentrated ownership structure with significant implications for stock price volatility [1][4]. Shareholding Distribution - As of December 31, 2025, 20 shareholders and their associates collectively held 1,387,094,033 shares, representing 18.79% of the company's issued share capital [1][3]. - Three major shareholders owned 5,310,485,115 shares, accounting for 71.94% of the issued share capital [1][3]. - Consequently, only 684,197,657 shares, or 9.27% of the issued share capital, were held by other shareholders [1][3]. Stock Price Performance - The closing price of Ximing Life Science shares increased from HKD 0.019 on September 10, 2025, to HKD 0.112 on December 31, 2025, marking a 489% rise [4]. - As of January 12, 2026, the stock price further rose to HKD 0.118, reflecting a 521% increase compared to the closing price on September 10, 2025 [4].
仅9.27%股份由其他股东持有 香港证监会点名信铭生命科技(00474)股权高度集中